Cargando…

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration

Objective: Antibody persistence evaluation for all antigens of a fully liquid DTaP-IPV-HB-PRP~T vaccine at 3.5 and 4.5 y of age following different primary series and booster schedules in South Africa and Latin America. Methods: Participants had completed one of two previous studies (Study 1-South A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madhi, Shabir A., López, Pío, Zambrano, Betzana, Jordanov, Emilia, B’Chir, Siham, Noriega, Fernando, Feroldi, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605714/ https://www.ncbi.nlm.nih.gov/pubmed/30513252 http://dx.doi.org/10.1080/21645515.2018.1546524

Ejemplares similares

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
por: Mangarule, S, et al.
Publicado: (2022)

Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa
por: Koen, Anthonet, et al.
Publicado: (2020)

03. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster Dose in Adults and Adolescents Vaccinated Against Meningococcal Disease 3 - 6 Years Earlier
por: Peterson, James, et al.
Publicado: (2021)

Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
por: Kosalaraksa, Pope, et al.
Publicado: (2018)

Kawasaki disease in an infant after administration of hexavalent vaccine
por: Almeshary, Meshal Z., et al.
Publicado: (2021)

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study
por: Zambrano, Betzana, et al.
Publicado: (2023)

Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
por: Mangarule, S., et al.
Publicado: (2022)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
por: Giambi, Cristina, et al.
Publicado: (2008)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”
por: McArthur, Monica Anne, et al.
Publicado: (2023)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan
por: Matsuoka, Osamu, et al.
Publicado: (2021)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

Hexavalent chromium (Contaminants)
Publicado: (2019)

2725. Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults
por: Hedrick, James, et al.
Publicado: (2019)

Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy
por: Nunes, Marta C, et al.
Publicado: (2018)

Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants
por: Moonsamy, Shelina, et al.
Publicado: (2019)

Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico
por: Lopardo, Gustavo, et al.
Publicado: (2014)

The lattice of the pre-booster and of the pre-holding rings
por: Dainelli, A, et al.
Publicado: (1989)

Pre-booster vacuum system
por: Botman, J
Publicado: (1989)

Hepatocyte FBXW7-dependent activity of nutrient-sensing nuclear receptors controls systemic energy homeostasis and NASH progression in male mice
por: Xia, Hui, et al.
Publicado: (2023)

Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines
por: Gentile, Angela, et al.
Publicado: (2023)

Biosorption of hexavalent chromium by Pleurotus ostreatus
por: da Rocha Ferreira, Glalber Luiz, et al.
Publicado: (2019)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study
por: Dhingra, M. S., et al.
Publicado: (2021)

Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia
por: Reynales, Humberto, et al.
Publicado: (2020)

Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies
por: Izu, Alane, et al.
Publicado: (2022)

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
por: Áñez, Germán, et al.
Publicado: (2020)

FCC-ee Pre-Booster Accelerators
por: Ogur, S, et al.
Publicado: (2017)

Polarization capabilities of EHF pre-booster
por: Galluccio, Francesca, et al.
Publicado: (1989)

The PS Booster as Pre-Injector for LHC
por: Schindl, Karlheinz
Publicado: (1997)

The PS booster as pre-injector for LHC
por: Schindl, K
Publicado: (1997)

Generation and characterization of monospecific and bispecific hexavalent trimerbodies
por: Blanco-Toribio, Ana, et al.
Publicado: (2013)

Phytofabrication of Iron Nanoparticles for Hexavalent Chromium Remediation
por: Truskewycz, Adam, et al.
Publicado: (2018)

Adverse hematological effects of hexavalent chromium: an overview
por: Ray, Rina Rani
Publicado: (2016)

Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology
por: Chiappini, E., et al.
Publicado: (2019)

Vaccination of HIV-infected pregnant women: implications for protection of their young infants
por: Dangor, Ziyaad, et al.
Publicado: (2017)

Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization
por: Feroldi, Emmanuel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3m94uaeq11ad3ho7mq4m0i235a